Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant
Moderna, Inc. has received marketing authorization from the European Commission for its updated COVID-19 vaccine, Spikevax, which targets the SARS-...